Glaxosmithkline Pharmaceuticals Ltd - GLAXOSMI. PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE159A01016
₹ 1,441.60 (0.70%) icon11 Aug, 2023, 3:52:38 PM
Open
₹ 1,431.60
Prev. Close
₹ 1,431.60
Turnover(lac)
₹ 1,332.07
Day's High
₹ 1,455.10
Day's Low
₹ 1,428.85
52 Wk High
₹ 1,487.00
52 Wk Low
₹ 1,227.00
Book Value
₹ 111.19
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 24,421.57
P/E
40.17
EPS
35.89
Div. Yield
2.22

Glaxosmithkline Pharmaceuticals Ltd Stock View

info icon
Edit Image
BUY
Target | 28 Jul, 2023 1,423.33 (-1.27%)

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the business of manufacturing, distributing, and trading in pharmaceuticals. It manufactures me... Read More

Glaxosmithkline Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 8/11/2023 3:52:38 PM

    ₹ 1441.6 10.00 0.70
  • Open
  • ₹ 1,431.6
  • Prev. Close
  • ₹ 1,431.6
  • Turnover(Lac.)
  • ₹ 1,332
  • Day's High
  • ₹ 1,455.1
  • Day's Low
  • ₹ 1,428.85
  • 52 Week's High
  • ₹ 1,487
  • 52 Week's Low
  • ₹ 1,227
  • Book Value
  • ₹ 111.19
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 24,421.57
  • P/E
  • 40.17
  • EPS
  • 35.89
  • Divi. Yield
  • 2.22

Glaxosmithkline Pharmaceuticals Ltd Corporate Actions

26 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 May , 2023

12:00 AM

AGM

Announcement date: 30 May , 2023

View Details

26 Jun , 2023

12:00 AM

17 May , 2023

12:00 AM

Dividend

Dividend amount: 32
Announcement date: 17 May , 2023

View Details

03 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Jan , 2023

12:00 AM

31 Oct , 2022

12:00 AM

31 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Glaxosmithkline Pharmaceuticals Ltd News and Update

Image not found
  • 11 August, 2023 |
  • 7:25 PM

The third-largest polluter in the world, France, has decided to purchase a 25% share in Adani New Industries Ltd. for an unknown sum to support green hydrogen projects there.

Image not found
Article Image
  • IIFL News Service |
  • 10 August, 2023 |
  • 7:24 PM
Image not found
  • IIFL News Service |
  • 10 August, 2023 |
  • 7:24 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Glaxosmithkline Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
14 August , 2023 | 07:26 AM

PROMOTER - TOTAL75.00%

Indian: 0.00%

Foreign: 75%

NON-PROMOTER - TOTAL 25.00%

Institutions: 12.66%

Non-Institutions: 12.34%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Glaxosmithkline Pharmaceuticals Ltd FINANCIALS

Glaxosmithkline Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Glaxosmithkline Pharmaceuticals Ltd

  • D Sundaram
  • Independent Director
  • A A Nadkarni
  • Company Sec. & Compli. Officer
  • P V Bhide
  • Independent Director
  • A N Roy
  • Independent Director
  • Subesh Williams
  • Director
  • Renu S Karnad
  • Chairperson
  • Sunita Maheshwari
  • Independent Director
  • Manu Anand
  • Independent Director
  • Bhushan Akshikar
  • Managing Director
  • J. Chandy
  • Whole Time Director & CFO

Summary

GlaxoSmithKline Pharmaceuticals Limited is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc, UK, one of the worlds leading research-based pharmaceutical and healthcare companies. The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.The Companys product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases. They also offer a range of vaccines, for the prevention of Hepatitis A, Hepatitis B, Invasive Disease caused by H, Influenza, Chickenpox, Diphtheria, Pertussis, Tetanus, Rotavirus, Cervical Cancer and Others. They have two manufacturing units in India, located at Nashik and Thane. Also, they have a clinical development centre in Bangalore. GlaxoSmithKline Pharma Limited was incorporated in November 13, 1924. During year 1956, the Company began primary production of vaccines at Worli. In the year 1960, the company started manufacturing Infant foods at milk drying plant at Aligarh. They also opened manufacturing facility for pharmaceuticals in Mumbai. In 1961, the Company started manufacturing Vitamin A and Betamethasone at new plant at Thane using imported raw materials. The Company registered as a limited company in the year 1968. Also, they introduced the Animal health products. In the... Read More


Reports by Glaxosmithkline Pharmaceuticals Ltd


Reports by Glaxosmithkline Pharmaceuticals Ltd

Company FAQ

No Record Found